The Economist18h
Volunteers with Down’s syndrome could help find Alzheimer’s drugs
And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been ...
precisionmedicineonline1d
FDA Accepts Eisai's BLA for Subcutaneous Leqembi Maintenance Dosing
The agency expects to issue a decision by Aug. 31, and it is slated to decide on maintenance dosing for an intravenous form of the drug later this month.
Why Alzheimer’s scientists are rethinking the amyloid hypothesis
Recent studies implicate the immune system and a herpes virus as potential contributors to development of disease ...
Alzheimer's Research UK5d
Working together to shape and expand brain health clinics across the uk
Right now, there isn’t a cure for people with dementia. But hope is on the horizon with lecanemab and donanemab – the first Alzheimer’s treatments licensed in Britain that can slow down the disease, ...
Alzheimer’s Drugs Eyed by Investors Seeking Obesity-Like Gains
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...